FDO Partners’s Edwards Lifesciences EW Stock Holding History

FDO Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,013	Closed	-$526K	–	39
2017 Q4	$526K	Sell	14,013 -25,176	-64%	-$924K	0.45%	96
2017 Q3	$1.43M	Buy	39,189 +16,056	+69%	+$612K	0.57%	68
2017 Q2	$912K	Sell	23,133 -106,650	-82%	-$3.89M	0.2%	178
2017 Q1	$4.07M	Buy	129,783 +73,782	+132%	+$2.31M	1.01%	22
2016 Q4	$1.75M	Buy	+56,001	New	+$1.81M	0.7%	59
2016 Q1	–	Sell	-39,966	Closed	-$1.05M	–	273
2015 Q4	$1.05M	Buy	+39,966	New	+$1.04M	0.6%	67

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FDO Partners's EW Position: Q1 2018 in Review

FDO Partners sold out of Edwards Lifesciences (EW) in Q1 2018, closing a stake of 14,013 shares — an estimated $526K sold.

FDO Partners first reported a position in EW in Q4 2015 and held it in 6 quarters. The position peaked at $4.07M in Q1 2017. 815 funds tracked by Wall St. Rank hold EW as of Q1 2018.

FDO Partners reported no remaining Edwards Lifesciences position as of Q1 2018 after selling out during the quarter.
FDO Partners sold 14,013 Edwards Lifesciences shares in Q1 2018, an estimated $526K.
FDO Partners first reported a position in Edwards Lifesciences in Q4 2015 and held it in 6 quarters.
FDO Partners's Edwards Lifesciences position peaked at $4.07M in Q1 2017.
815 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2018.

Based on FDO Partners's 13F filing for Q1 2018, filed 14 May 2018.